OMB files this
comment on the proposed rule and requests that DEA respond to all
comments received on the proposed rule related to this information
collection.
Inventory as of this Action
Requested
Previously Approved
09/30/2021
36 Months From Approved
09/30/2021
15,919
0
15,919
2,076
0
2,076
175,109
0
175,109
The Controlled Substances Act requires
all businesses and individuals who manufacture, distribute, import,
export, and conduct research and laboratory analysis with
controlled substances to register with the DEA. 21 U.S.C. 822, 21
CFR 1301.11 and 1301.13. Registration is a necessary control
measure that prevents diversion by ensuring the closed system of
distribution of controlled substances can be monitored by the DEA
and that the businesses and individuals handling controlled
substances are qualified to do so and are accountable.
US Code:
21
USC 822 Name of Law: Persons Required to Register
The increase in annual
responses and burden hours reflects the increase in the DEA's
registrant population. The decrease in annual cost is due to a
lower estimated hourly rate for employees completing the
responses.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.